River Global Investors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$2.36M Sell
28,547
-18,520
-39% -$1.46M 0.46% 40
2024
Q3
$3.37M Buy
47,067
+331
+0.7% +$23.4K 0.72% 30
2024
Q2
$3.2M Buy
46,736
+6,664
+17% +$398K 0.88% 28
2024
Q1
$2.15M Buy
40,072
+12,896
+47% +$693K 0.54% 56
2023
Q4
$1.45M Buy
+27,176
New +$1.32M 0.27% 112

Other funds holding GMED

River Global Investors's GMED Position: Q4 2024 in Review

River Global Investors reduced its Globus Medical (GMED) stake by 39% in Q4 2024, selling an estimated $1.46M and leaving 28,547 shares worth $2.36M. The position accounts for 0.46% of the portfolio, ranked #40.

River Global Investors first reported a position in GMED in Q4 2023 and has held it in 5 quarters since. The position peaked at $3.37M in Q3 2024. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

  • River Global Investors held 28,547 shares of Globus Medical worth $2.36M as of Q4 2024.
  • River Global Investors sold 18,520 Globus Medical shares in Q4 2024, an estimated $1.46M.
  • Globus Medical made up 0.46% of River Global Investors's portfolio in Q4 2024, its #40 holding.
  • River Global Investors first reported a position in Globus Medical in Q4 2023 and has held it in 5 quarters since.
  • River Global Investors's Globus Medical position peaked at $3.37M in Q3 2024.
  • 500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on River Global Investors's 13F filing for Q4 2024, filed 7 Feb 2025.